Abstract: A system for electronically supervised administration of a pharmaceutical composition, that comprises an authorised entity node (100, 200) for an authorised entity, a mobile device (300) of a patient, and a medical device (400) adapted to administer the pharmaceutical composition, wherein the authorised entity node (100, 200) is adapted, when operated by the authorised entity, to generate data corresponding to an administration scheme (11) and an authorisation token (12) for assigning to a patient's mobile device (300), and to send the data corresponding to an administration scheme (11) and authorisation token (12) to the patient's mobile device (300).

Abstract: An inhaler (400) for electronically supervised parenteral administration of a dry powder pharmaceutical composition comprising: storage means (410) for the pharmaceutical composition in a form of a dry powder; administration means (411) for ad- ministration of the pharmaceutical composition; memory (404) and processing means (402); communication means (401); controlled blocking means (403) for blocking administration of the pharmaceutical composition, wherein the inhaler (400) is adapted to receive data corresponding to an administration scheme (11), to determine whether a mobile device (300) with an authorisation token assigned thereto is present, and to control the controlled blocking means (403) so as to allow administration of the pharmaceutical composition only with compliance with the administration scheme (11) in the presence of the mobile device (300) with the authorisation token (12) assigned thereto.